NR1H2 and cancer: Liver X receptorβ (LXRβ, also known as NR1H2) is a nuclear receptor, which is considered as the core of modern pharmacology, and the promising therapeutic target for lipid disorders, atherosclerosis, chronic inflammation, autoimmunity, cancer and neurodegenerative diseases1, 2.